Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
83 studies found for:    Open Studies | "Mouth Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
Conditions: Erythroplakia;   Hyperplasia;   Mild Dysplasia;   Moderate Dysplasia;   Oral Cavity Carcinoma;   Oral Leukoplakia;   Severe Dysplasia
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformin Hydrochloride
22 Recruiting Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care
Conditions: Lip and Oral Cavity Squamous Cell Carcinoma;   Oral Cavity Verrucous Carcinoma;   Stage 0 Lip and Oral Cavity Cancer;   Tongue Cancer
Interventions: Procedure: fluorescence imaging;   Procedure: biopsy;   Procedure: examination;   Procedure: Comparison of surgical margins by COE vs. DVFE
23 Not yet recruiting Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
Conditions: Tongue Neoplasms;   Tongue Cancer;   Oral Cancer
Interventions: Device: Palatal Augmentation Prosthesis (PAP);   Other: Articulation Therapy
24 Recruiting Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+
Condition: Squamous Cell Carcinoma of Oral Cavity
Intervention: Drug: tegafur-uracil
25 Recruiting Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
Conditions: Oropharyngeal Cancer;   Oral Cancer;   Lymph Node Metastasis
Intervention: Radiation: Radiation therapy
26 Not yet recruiting Study of Pembrolizumab (MK-3475) for High Risk Oral Intra-Epithelial Neoplasias
Conditions: Oral Pre-malignant Lesion(s);   Intra-epithelial Neoplasias;   History of Invasive Oral Cancer
Intervention: Drug: Pembrolizumab
27 Recruiting uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
Conditions: Oral Cancer;   Oropharyngeal Cancer;   Neoplasms;   Head and Neck Neoplasms;   Cancer of Mouth;   Neoplasms by Site
Intervention: Other: 68Ga-NOTA-AE105 PET/CT
28 Recruiting Patient Evaluation for Head and Neck Surgery Branch Studies
Conditions: Head and Neck Neoplasms;   Pharyngeal Cancer;   Oral Cancer;   Carcinoma, Squamous Cell;   Laryngeal Cancer
29 Recruiting Early Diagnosis of Oral Cancer by Detecting p16 Hydroxymethylation
Condition: Oral Epithelial Dysplasia
Intervention: Other: no intervention
30 Recruiting Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer
Condition: Oral Squamous Cell Carcinoma
Intervention: Other: saliva collection prior to clinically driven oral biopsy
31 Recruiting Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer
Condition: Head and Neck Cancer
Interventions: Genetic: microarray analysis;   Genetic: allele-specific oligonucleotide real-time quantitative polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis
32 Recruiting Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer
Conditions: Stage I Oral Cavity Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma
Interventions: Drug: HPPH;   Other: Laboratory Biomarker Analysis;   Drug: Photodynamic Therapy;   Other: Quality-of-Life Assessment;   Procedure: Therapeutic Conventional Surgery
33 Not yet recruiting Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer
Condition: Oral Cavity Squamous Cell Carcinoma
Interventions: Device: Computed Tomography;   Device: Positron Emission Tomography and Computed Tomography Scan;   Device: Cone-Beam Computed Tomography;   Device: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Histopathologic Examination
34 Recruiting Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan
Condition: Head and Neck Neoplasms
35 Recruiting Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma
Condition: Oral Squamous Cell Carcinoma
Intervention: Drug: Celecoxib
36 Not yet recruiting ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Conditions: Oral Cavity Neoplasm;   Oropharyngeal Neoplasm;   Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;   Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7;   Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;   Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7;   Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;   Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7;   Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;   Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7;   Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;   Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7;   Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;   Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7;   Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;   Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet;   Other: Pharmacological Study;   Other: Placebo
37 Recruiting Adaptive Radiotherapy for Head and Neck Cancer
Conditions: Head and Neck Cancer;   Paranasal Sinus Cancer;   Oropharynx Cancer;   Oral Cavity Cancer;   Nasopharynx Cancer;   Larynx Cancer;   Hypopharynx Cancer
Intervention: Radiation: Adaptive Radiotherapy
38 Recruiting Pembrolizumab in Combination With CRT for LA-SCCHN
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma;   Oral Cavity Cancer;   Oropharynx Cancer;   Hypopharynx Cancer;   Larynx Cancer;   Laryngeal Cancer
Interventions: Drug: pembrolizumab (MK-3475);   Drug: Cisplatin;   Radiation: Radiation
39 Recruiting Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
Conditions: HNSCC;   Lip SCC;   Oral Cavity Cancer;   Oropharynx Cancer;   Larynx Cancer;   Hypopharynx Cancer;   Nasopharynx Cancer;   Sinonasal Carcinoma;   Cutaneous Squamous Cell Carcinoma;   Head and Neck Neoplasms;   Head and Neck Cancer;   Head and Neck Squamous Cell Carcinoma
Intervention: Drug: Pembrolizumab, Cetuximab
40 Recruiting A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery
Conditions: Colorectal Neoplasms;   Urologic Neoplasms;   Urologic Diseases;   Nasopharyngeal Neoplasms;   Oropharyngeal Neoplasms;   Oral Neoplasms;   Hypopharyngeal Neoplasms;   Laryngeal Neoplasms;   ENT Diseases
Intervention: Procedure: Robotic single port surgery and NOTES

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.